Results 9,681-9,700 of 14,090 for speaker:Marc MacSharry
- Public Accounts Committee: Business of Committee (8 Nov 2018)
Marc MacSharry: As it will know a lot more than us, I would not worry about it.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: I welcome the witnesses. Who in the State Claims Agency directs a case? If I am taking a case, I brief my solicitor on the outcome I would like to achieve. Who in the State Claims Agency does this?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: When a case ends up with the State Claims Agency, is the agency briefed by the Department or the Minister or is its only modus operandito protect the State and minimise exposure?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Or a Minister, if the action is being taken against him or her or any of the State agencies within his or her remit.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Does the State Claims Agency have plenipotentiary status to direct a case without any toing and froing with the Department or the Minister or does that interaction take place?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: I understand that. Mr. Breen says the State Claims Agency investigates it. It investigates matters with its preferred outcome, which is presumably to minimise exposure to the State.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Mr. Breen might have referred to this with Deputy Connolly earlier. In cases overall, how often does the agency pay people off or settle without any litigation and say there might be an issue and that the agency is prepared to pay a certain amount?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Normally the agency would not, so it would end up in court.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: What percentage ends up in court?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Is being under case management different from being in court? I do not know the legalese.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: When Mr. Breen says "in court", he is not including that process.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: In the room?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: With regard to litigation, Mr. Breen would not associate discovery as being in court.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: I am maybe not as up to date on the thalidomide issue as some other members. An offer of €62,500 was made. Had Mr. Breen a different role in the State Claims Agency at that point?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: So he was negotiating and made this offer.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Is it true that an offer was made at 4 p.m. after the courts had closed, giving a deadline of 12 midnight for a response?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: Was this 1 August?
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: I think it was 31 July.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: That caused a difficulty because there were some people with mental capacity issues and a High Court judge had to be found.
- Public Accounts Committee: Matters related to Medical Negligence, Open Disclosure, Cervical Cancer and Thalidomide Litigation (8 Nov 2018)
Marc MacSharry: To somebody untrained such as me, it looks like sharp practice. Would that be a fair point?